Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Free of gastrointestinal disease (gastrointestinal cancer, inflammatory bowel disease, bariatric surgery, irritable bowel syndrome)
Willing to not schedule a colonoscopy during the 13-week study
Must not have
Diabetes mellitus (type 1, or type 2 with insulin therapy)
Treatment with immunosuppressive drugs
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline when compared with the week-13 visit
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to improve muscle health in older adults by targeting the gut with a diet enriched in fiber to feed beneficial bacteria.
Who is the study for?
This trial is for non-smoking, English-speaking older adults over 65 who live independently and lead a sedentary lifestyle. They should be free of gastrointestinal diseases, willing to eat high-soluble fiber foods without major dietary restrictions or allergies, and not planning significant weight changes or medical procedures that could affect the study.
What is being tested?
The study tests how diets with different levels of soluble fiber affect gut bacteria and muscle health in older adults. Participants will follow either a low-soluble fiber diet or a high-soluble fiber diet for 13 weeks to see if there's an impact on their muscle-related measures.
What are the potential side effects?
Participants may experience mild gastrointestinal discomfort such as bloating, belly grumbling, and flatulence due to the high intake of soluble-fiber-rich foods. The study aims to minimize these side effects by adjusting food choices when possible.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I do not have any gastrointestinal diseases.
Select...
I agree not to have a colonoscopy during the 13-week study.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have diabetes and use insulin.
Select...
I am currently taking drugs that suppress my immune system.
Select...
My BMI is under 18.5, indicating malnutrition.
Select...
I have lost or gained more than 5% of my weight in the last 6 months.
Select...
I have a diagnosed condition like cancer, dementia, or heart disease.
Select...
My kidney function is severely reduced.
Select...
I am unable to visit the Tufts HNRCA 3 times a week for my diet.
Select...
I do not have any active infections like TB, HIV, malaria, hepatitis, shingles, MRSA, or COVID-19.
Select...
I have had organ failure in the past (heart, liver, kidney, or lungs).
Select...
I have had an injury or surgery that affects my physical abilities.
Select...
I regularly take anti-inflammatory medication.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline when compared with the week-13 visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline when compared with the week-13 visit
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Chair stand test
Fatty Acids, Volatile
Quantification of hand grip strength
+1 moreSecondary study objectives
Walk Test
Quantification of gut bacterial composition in fecal samples
Bacteria
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Low-soluble fiber dietExperimental Treatment1 Intervention
Group II: High-soluble fiber dietActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Tufts UniversityLead Sponsor
270 Previous Clinical Trials
596,094 Total Patients Enrolled
9 Trials studying Sarcopenia
700 Patients Enrolled for Sarcopenia
Michael S Lustgarten, PhDStudy DirectorScientist II, NEPS Laboratory
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have diabetes and use insulin.I am currently taking drugs that suppress my immune system.My BMI is under 18.5, indicating malnutrition.I have lost or gained more than 5% of my weight in the last 6 months.I am over 65 years old and live independently.My kidney function is severely reduced.You don't do much physical activity in your free time.You have allergies to any of the foods used in the study.I am unable to visit the Tufts HNRCA 3 times a week for my diet.I haven't taken probiotics, antibiotics, new drugs, or changed my medication in the last month.You are not currently eating a lot of high-fiber foods.I do not have any active infections like TB, HIV, malaria, hepatitis, shingles, MRSA, or COVID-19.I have a diagnosed condition like cancer, dementia, or heart disease.I have had organ failure in the past (heart, liver, kidney, or lungs).I do not have any gastrointestinal diseases.I agree not to have a colonoscopy during the 13-week study.I have had an injury or surgery that affects my physical abilities.Difficulty chewingYou have had a problem with drinking too much alcohol in the past 5 years.I regularly take anti-inflammatory medication.You are okay with feeling a little discomfort in your stomach, like bloating or gas, and we will try to give you different foods if needed.Willing to eat a lot of foods that are high in soluble fiber, like broccoli, brussels sprouts, flaxseeds sweetened with dates, lima beans, butternut squash, carrots, and collard greens.I am unwilling to wear a step counter daily.You do not smoke cigarettes.
Research Study Groups:
This trial has the following groups:- Group 1: Low-soluble fiber diet
- Group 2: High-soluble fiber diet
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger